Skip to main content
. Author manuscript; available in PMC: 2015 Apr 23.
Published in final edited form as: Epilepsy Behav. 2012 Feb 29;23(3):353–359. doi: 10.1016/j.yebeh.2012.01.013

Table 1.

Patient characteristics.

Patient Gender Absence Myoclonic JME Convulsion Onset age Age at MRI AEDs
1 M X X X 4 26 TPM
2 F X X X 17* 48 LTG
3 M X X 20 27 LEV
4 F X 19 32 LEV
5 F X X X 13 22 LEV, LTG
6 F X X 18* 21 ETX, LTG
7 F X 13 39 LEV, LTG, RUF, TPM
8 M X X X 2 27 CBZ, VPA
9 M X 9 35 LEV
10 M X 31 36 VPA
11 M X X X 12 25 OXC, ZNG
12 F X X X X 15 24 CLZ, LTG
13 M X 15 20 LEV, TPM, VPA
14 F X X X 14 37 CLZ, LEV
15 F X X X X 10 27 TPM

CBZ=carbamazepine, ETX=ethosuximide, CLZ=clonazepam, LEV=levetiracetam, LTG=lamotrigine, OXC=oxcarbazepine, RUF=rufinamide, TPM=topiramate, VPA=valproic acid, ZNG=zonisamide.

*

Patients were diagnosed with IGE based on scalp EEG and presentation to a hospital after first general tonic-clonic convulsion. It is unclear though possible that they experienced staring spells that would be consistent with absence epilepsy prior to this age of diagnosis though they did experience absence seizures after onset age that were captured on video EEG.